Surveillance of lymphatic filariasis after stopping ten years of mass drug administration in rural communities in South India

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 107, Issue 5, 2013, Pages 293-300

  Ramaiah, K D ^a   Vanamail, P ^a  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

Author keywords

DEC; Elimination; India; Lymphatic filariasis; Mass drug administration; Surveillance

Indexed keywords

ALBENDAZOLE; DIETHYLCARBAMAZINE;

ADULT; ARTICLE; CHILD; CLINICAL ASSESSMENT; CLINICAL DECISION MAKING; CLINICAL EVALUATION; COMMUNITY CARE; CONTROLLED STUDY; ENDEMIC DISEASE; EPIDEMIOLOGICAL MONITORING; FEMALE; HEALTH SURVEY; HUMAN; INCIDENCE; INDIA; INFECTION; INFECTION CONTROL; INFECTION RATE; LYMPHATIC FILARIASIS; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PREVALENCE; RURAL POPULATION; SCHOOL CHILD;

EID: 84880615065     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1093/trstmh/trt011     Document Type: Article

References (32)

1. Centre for Disease Control. Recommendations of the International Task Force for Disease Eradication. MMWR Morb Mortal Wkly Rep1993;42:1-38.
2. Ottesen EA. The global programme to eliminate lymphatic filariasis. Trop Med Int Health 2000;5:591-4.
3. World Health Organization. Global programme to eliminate lymphatic filariasis - progress report on mass drug administration in 2008. Wkly Epidemiol Rec 2009; 84:437-44.
4. Centerd for Disease Control. Progress towards elimination of lymphatic filariasis - Togo, 2000-2009. MMWR Morb Mortal Wkly Rep 2011;60:989-91.
5. Ramaiah KD, Vanamail P, Yuvaraj J, Das PK. Effect of annual mass administration of six rounds of diethylcarbamazine and albendazole on bancroftian filariasis in five villages in south India. Trans R Soc Trop Med Hyg 2011;105:431-7.
6. Richards FO, Eigege A, Miri ES et al. Epidemiological and entomological evaluations after six years or more of mass drug administration for lymphatic filariasis elimination in Nigeria. Plos Negl Trop Dis 2011; 5:e1346.
7. Ramzy RM, El Setouhy M, Helmy H et al. Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment. Lancet 2006;367:992-9.
8. Ramaiah KD, Das PK, Vanamail P, Pani SP. Impact of ten years of diethylcarbamazine and ivermectin mass administration on infection and transmission of lymphatic filariasis. Trans R Soc Trop Med Hyg 2007;101:555-63.
9. WHO. Monitoring and Epidemiological Assessment of the Programme to Eliminate Lymphatic Filariasis at Implementation Unit Level. Geneva: World Health Organization; 2005. WHO/CDS/CPE/CEE/2005.50.
10. Weil GJ, Lammie PJ, Weiss N. The ICT filariasis test: a rapid format antigen test for diagnosis of bancroftian filariasis. Parasitol Today 1997;13:401-4.
11. WHO. Lymphatic Filariasis: Monitoring and Epidemiological Assessment of Mass Drug Administration. TAS. A Manual for National Elimination Programmes. Geneva: World Health Organization; 2011. WHO/HTM/NTD/PCT/2011.4.
12. Sasa M. Human Filariasis - A Global Survey of Epidemiology and Control. Baltimore: University Park Press; 1976.
13. Gyapong JO, Kumaraswami V, Biswas G, Ottesen EA. Treatment strategies underpinning the global programme to eliminate lymphatic filariasis. Expert Opin Pharmacother 2005;6:179-200.
14. Farid HA, Hammad RE, Soliman DA et al. Relationship between Wuchereria bancrofti microfilaria counts in human blood and parasite uptake and maturation in Culex pipiens, with observations on the effects of diethylcarbamazine treatment on these parameters. Am J Trop Med Hyg 2003;68:286-93.
15. Subramanian S, Krishnamoorthy K, Ramaiah KD et al. The relationship between microfilarial load in the human host and uptake and development of Wuchereria bancrofti microfilariae by Culex quinquefasciatus: a study under natural conditions. Parasitology 1998;116:243-55.
16. McGreevy PB, Kolstrup N, Tao J et al. Ingestion and development of Wuchereria bancrofti in Culex quinquefasciatus, Anopheles gambiae and Aedes aegypti after feeding on humans with varying densities of microfilariae in Tanzania. Trans R Soc Trop Med Hyg 1982;76:288-96.
17. Farid HA, Morsy ZS, Helmy H et al. A critical appraisal of molecular xenomonitoring as a tool for assessing progress towards elimination of lymphatic filariasis AmJ Trop Med Hyg 2007;77: 593-600.
18. Michael E, Ramaiah KD, Hoti SL et al. Quantifying mosquito biting patterns on humans by DNA finger printing of blood meals. Am J Trop Med Hyg 2001;65:S722-8.
19. WHO. Defining the roles of vector control and xenomonitoring in the global programme to eliminate lymphatic filariasis. Report of the Informal Consultation WHO/HQ, Geneva, 29-31 January 2002. Geneva: World Health Organization; 2002; WHO/CDS/CPE/PVC/2002.3
20. Burkot T, Ichimori K. The PacELF programme: will mass administration be enough? Trends Parasitol 2002;18:109-15.
21. Lammie PJ, Weil G, Noordin R et al. Recombinant antigen based antibody assays for the diagnosis and surveillance of lymphatic filariasis: a multi-center trial. Filaria J 2004;3:9.
22. Ramaiah KD, Das PK, Vanamail P. Changes in Wuchereria bancrofti infection in a highly endemic community following 10 rounds of mass administration of diethylcarbamazine. Trans R Soc Trop Med Hyg 2007;101:250-5.
23. Mitja O, Paru R, Hays R et al. The impact of filariasis control program on Lihir island, Papua New Guinea. PLos Neg Trop Dis 2011;5:e1286.
24. Ramaiah KD, Vanamail P, Pani SP, Das PK. The prevalence of Wuchereria bancrofti antigenaemia in communities given six rounds of treatment with diethylcarbamazine, ivermectin or placebo tablets. Ann Trop Med Parasit 2003;97:737-41.
25. Foo PK, Tarozzi A, Mahajan A et al. High prevalence of Wuchereria bancrofti infection as detected by immunochromatographic card testing in five districts of Orissa, India, previously considered to be non-endemic. Trans R Soc Trop Med Hyg 2011;105:109-14.
26. Chhotray GP, Ranjit MR, Khuntia HK, Acharya AS. Pre-control observations on lymphatic filariasis and geo-helminthiases in two coastal districts of rural Orissa. Indian J Med Res 2005; 122:388-94.
27. Chanteau S, Moulia-Pelat JP, Glaziou P et al. Og4C3 circulating antigen: a marker of infection and adult worm burden in Wuchereria bancrofti filariasis. J Infect Dis 1994;120:247-50.
28. Subramanian S, Stolk WA, Ramaiah KD et al. The dynamics of Wuchereria bancrofti infection: a model based analysis of longitudinal data from Pondicherry, India. Parasitology 2004;128:467-82.
29. Vanamail P, Ramaiah KD, Pani SP et al. Estimation of the fecund life span of Wuchereria bancrofti in an endemic area. Trans R Soc Trop Med Hyg 1996;90:119-21.
30. Tisch DJ, Bockarie MJ, Dimber Z et al. Mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea: changes in microfilaraemia, filarial antigen, and Bm14 antibody after cessation. Am J Trop Med Hyg 2008;78:289-93.
31. Wamae CN, Njenga SM, Ngugi BM et al. Evaluation of effectiveness of diethylcarbamazine/albendazole combination in reduction of Wuchereria bancrofti infection using multiple infection parameters. Acta Trop 2011;120(Suppl 1):S33-8.
32. Rajendran R, Sunish IP, Mani TR et al. Community-based study to assess the efficacy of DEC plus ALB against DEC alone on bancroftian filarial infection in endemic areas in Tamil Nadu, south India. Trop Med Int Health 2006;11:851-61.